Bill > HB1463

This bill amends Mississippi law to require manufacturers of pseudoephedrine (PSE) and ephedrine products to pay monthly fees to the National Association of Drug Diversion Investigators (NADDI) to support the National Precursor Log Exchange (NPLEx) system, starting October 1, 2025. The NPLEx is an electronic tracking system used to monitor and prevent the illegal purchase of PSE and ephedrine, which can be used to manufacture methamphetamine. Currently, the law already requires pharmacies to use this system when selling over-the-counter PSE products, tracking sales through electronic logs, verifying purchaser identification, and limiting daily and monthly purchase amounts. The new provision places the financial responsibility for maintaining the NPLEx system on manufacturers, with NADDI being responsible for setting the fee levels. Manufacturers must provide documentation of fee payment upon request by the State Board of Pharmacy. The bill maintains existing provisions about sales restrictions, such as requiring purchasers to be at least 18 years old, presenting valid identification, and limiting purchase quantities. Violations of these regulations remain classified as misdemeanors with escalating fines for repeat offenses.